These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35741827)

  • 21. Acromesomelic dysplasia-Maroteaux type, nine patients with two novel
    Kılıç E; Çavdarlı B; Büyükyılmaz G; Kılıç M
    J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1115-1121. PubMed ID: 34162036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in C-natriuretic peptide (NPPC): a novel cause of autosomal dominant short stature.
    Hisado-Oliva A; Ruzafa-Martin A; Sentchordi L; Funari MFA; Bezanilla-López C; Alonso-Bernáldez M; Barraza-García J; Rodriguez-Zabala M; Lerario AM; Benito-Sanz S; Aza-Carmona M; Campos-Barros A; Jorge AAL; Heath KE
    Genet Med; 2018 Jan; 20(1):91-97. PubMed ID: 28661490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High prevalence of variants in skeletal dysplasia associated genes in individuals with short stature and minor skeletal anomalies.
    Sentchordi-Montané L; Benito-Sanz S; Aza-Carmona M; Díaz-González F; Modamio-Høybjør S; de la Torre C; Nevado J; Ruiz-Ocaña P; Bezanilla-López C; Prieto P; Bahíllo-Curieses P; Carcavilla A; Mulero-Collantes I; Barreda-Bonis AC; Cruz-Rojo J; Ramírez-Fernández J; Bermúdez de la Vega JA; Travessa AM; González de Buitrago Amigo J; Del Pozo A; Vallespín E; Solís M; Goetz C; Campos-Barros Á; Santos-Simarro F; González-Casado I; Ros-Pérez P; Parrón-Pajares M; Heath KE
    Eur J Endocrinol; 2021 Oct; 185(5):691-705. PubMed ID: 34516402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of children born small for gestational age with short stature who qualify for growth hormone treatment.
    Tamaro G; Pizzul M; Gaeta G; Servello R; Trevisan M; Böhm P; Materassi PMA; Macaluso A; Valentini D; Pellegrin MC; Barbi E; Tornese G
    Ital J Pediatr; 2021 Apr; 47(1):82. PubMed ID: 33794966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
    Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT
    Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel variants in natriuretic peptide receptor 2 in unrelated patients with acromesomelic dysplasia type Maroteaux.
    Ain NU; Iqbal M; Valta H; Emerling CA; Ahmed S; Makitie O; Naz S
    Eur J Med Genet; 2019 Sep; 62(9):103554. PubMed ID: 30359775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Children born small-for-gestational age: postnatal growth and hormonal status.
    Albertsson-Wikland K; Boguszewski M; Karlberg J
    Horm Res; 1998; 49 Suppl 2():7-13. PubMed ID: 9730665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
    Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the natriuretic peptide system in normal growth and growth disorders.
    Vasques GA; Arnhold IJ; Jorge AA
    Horm Res Paediatr; 2014; 82(4):222-9. PubMed ID: 25196103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unveiling the pathogenic mechanisms of NPR2 missense variants: insights into the genotype-associated severity in acromesomelic dysplasia and short stature.
    Badawi S; Varghese DS; Raj A; John A; Al-Musafir HS; Al-Ghamari AJ; Alshamsi AR; Ouda SH; Al-Dirbashi G; Ali BR
    Front Cell Dev Biol; 2023; 11():1294748. PubMed ID: 38078000
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of Diagnostic Variants in
    Zhu J; Meng R; Zhao H; Cai L; Wen X; Zeng W; Luo Y; Qi H
    DNA Cell Biol; 2022 Nov; 41(11):996-1006. PubMed ID: 36322898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A High Proportion of Novel ACAN Mutations and Their Prevalence in a Large Cohort of Chinese Short Stature Children.
    Lin L; Li M; Luo J; Li P; Zhou S; Yang Y; Chen K; Weng Y; Ge X; Mireguli M; Wei H; Yang H; Li G; Sun Y; Cui L; Zhang S; Chen J; Zeng G; Xu L; Luo X; Shen Y
    J Clin Endocrinol Metab; 2021 Jun; 106(7):e2711-e2719. PubMed ID: 33606014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of small for gestational age (SGA) and short stature in children born SGA who qualify for growth hormone treatment at 3 years of age: Population-based study.
    Fujita K; Nagasaka M; Iwatani S; Koda T; Kurokawa D; Yamana K; Nishida K; Taniguchi-Ikeda M; Uchino E; Shirai C; Iijima K; Morioka I
    Pediatr Int; 2016 May; 58(5):372-6. PubMed ID: 26617415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Characteristics of Short-Stature Patients With Collagen Gene Mutation and the Therapeutic Response to rhGH.
    Chen M; Miao H; Liang H; Ke X; Yang H; Gong F; Wang L; Duan L; Chen S; Pan H; Zhu H
    Front Endocrinol (Lausanne); 2022; 13():820001. PubMed ID: 35250876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
    Ross JL; Lee PA; Gut R; Germak J
    Growth Horm IGF Res; 2015 Dec; 25(6):286-93. PubMed ID: 26363846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenic/likely pathogenic variants in the SHOX, GHR and IGFALS genes among Indian children with idiopathic short stature.
    Kumar A; Jain V; Chowdhury MR; Kumar M; Kaur P; Kabra M
    J Pediatr Endocrinol Metab; 2020 Jan; 33(1):79-88. PubMed ID: 31834863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A heterozygous point mutation of the ANKRD11 (c.2579C>T) in a Chinese patient with idiopathic short stature.
    Kang Y; He D; Li Y; Zhang Y; Shao Q; Zhang M; Ban B
    Mol Genet Genomic Med; 2019 Dec; 7(12):e988. PubMed ID: 31566922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel aggrecan variant, p. Gln2364Pro, causes severe familial nonsyndromic adult short stature and poor growth hormone response in Chinese children.
    Xu D; Sun C; Zhou Z; Wu B; Yang L; Chang Z; Zhang M; Xi L; Cheng R; Ni J; Luo F
    BMC Med Genet; 2018 May; 19(1):79. PubMed ID: 29769040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further defining the clinical and molecular spectrum of acromesomelic dysplasia type maroteaux: a Turkish tertiary center experience.
    Simsek-Kiper PO; Urel-Demir G; Taskiran EZ; Arslan UE; Nur B; Mihci E; Haliloglu M; Alanay Y; Utine GE; Boduroglu K
    J Hum Genet; 2021 Jun; 66(6):585-596. PubMed ID: 33288834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De novo c.2455C>T mutation of NPR2 gene in a fetus with shortened long bones and a ventricular septal defect conceived by a mother with a fragile site at 16q22.1 and a father with a rare heterochromatic variant of chromosome 4 from Vietnam.
    Ha TMT; Nguyen TTN; Nguyen TMN; Nguyen HN
    Mol Genet Genomic Med; 2021 Apr; 9(4):e1637. PubMed ID: 33713577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.